| - GRCh37:
- Chr3:148742000
- GRCh38:
- Chr3:149024213
| GYG1 | V257I | Polyglucosan body myopathy type 2, Glycogen storage disease XV | Uncertain significance (Mar 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148744703
- GRCh38:
- Chr3:149026916
| GYG1 | D346Y, L255F, D329Y | Inborn genetic diseases, Glycogen storage disease XV, Polyglucosan body myopathy type 2
| Uncertain significance (Jul 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:148714128
- GRCh38:
- Chr3:148996341
| GYG1 | | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Likely benign (Mar 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148714542
- GRCh38:
- Chr3:148996755
| GYG1 | I111T | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Uncertain significance (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148714639
- GRCh38:
- Chr3:148996852
| GYG1 | | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Likely benign (May 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148744547
- GRCh38:
- Chr3:149026760
| GYG1 | E294Q, E277Q | Inborn genetic diseases, Glycogen storage disease XV, Polyglucosan body myopathy type 2
| Uncertain significance (May 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:148741903
- GRCh38:
- Chr3:149024116
| GYG1 | | Polyglucosan body myopathy type 2, Glycogen storage disease XV | Likely benign (May 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148727063
- GRCh38:
- Chr3:149009276
| GYG1 | G161D | Polyglucosan body myopathy type 2, Glycogen storage disease XV | Uncertain significance (Apr 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148709451
- GRCh38:
- Chr3:148991664
| GYG1 | | Polyglucosan body myopathy type 2, Glycogen storage disease XV | Likely benign (Jan 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148727178
- GRCh38:
- Chr3:149009391
| GYG1 | | Polyglucosan body myopathy type 2, Glycogen storage disease XV | Uncertain significance (Dec 21, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148744583
- GRCh38:
- Chr3:149026796
| GYG1 | L215F, G306W, G289W | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Uncertain significance (Sep 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148714585
- GRCh38:
- Chr3:148996798
| GYG1 | | Polyglucosan body myopathy type 2, Glycogen storage disease XV | Likely benign (Jul 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148744540
- GRCh38:
- Chr3:149026753
| GYG1 | | Polyglucosan body myopathy type 2, Glycogen storage disease XV | Likely benign (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148727072
- GRCh38:
- Chr3:149009285
| GYG1 | Q164R | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Uncertain significance (Aug 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148741864
- GRCh38:
- Chr3:149024077
| GYG1 | | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Likely benign (Feb 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148741827
- GRCh38:
- Chr3:149024040
| GYG1 | | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Likely benign (Mar 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148714283
- GRCh38:
- Chr3:148996496
| GYG1 | | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Likely benign (May 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148727178
- GRCh38:
- Chr3:149009391
| GYG1 | | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Likely benign (Apr 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148727082
- GRCh38:
- Chr3:149009295
| GYG1 | | Polyglucosan body myopathy type 2, Glycogen storage disease XV | Likely benign (Apr 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148744620
- GRCh38:
- Chr3:149026833
| GYG1 | R228W, S301L, S318L | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Uncertain significance (Jul 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148711977
- GRCh38:
- Chr3:148994190
| GYG1 | A19V | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Uncertain significance (Feb 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148744303
- GRCh38:
- Chr3:149026516
| GYG1 | | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Likely benign (Jan 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148714269
- GRCh38:
- Chr3:148996482
| GYG1 | | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Uncertain significance (Jul 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148714528
- GRCh38:
- Chr3:148996741
| GYG1 | | Polyglucosan body myopathy type 2, Glycogen storage disease XV | Pathogenic (Mar 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148714196
- GRCh38:
- Chr3:148996409
| GYG1 | L84P | Inborn genetic diseases, Polyglucosan body myopathy type 2, Glycogen storage disease XV
| Uncertain significance (Jun 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:148714217
- GRCh38:
- Chr3:148996430
| GYG1 | S91L | Polyglucosan body myopathy type 2, Glycogen storage disease XV | Uncertain significance (Mar 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148714621
- GRCh38:
- Chr3:148996834
| GYG1 | | Polyglucosan body myopathy type 2, Glycogen storage disease XV | Likely benign (Jun 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148744261
- GRCh38:
- Chr3:149026474
| GYG1 | L284R | Polyglucosan body myopathy type 2, Glycogen storage disease XV | Uncertain significance (Jan 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148711916
- GRCh38:
- Chr3:148994129
| GYG1 | | Polyglucosan body myopathy type 2, Glycogen storage disease XV | Likely benign (Jul 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148714650
- GRCh38:
- Chr3:148996863
| GYG1 | N147S | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Uncertain significance (Jul 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148744621
- GRCh38:
- Chr3:149026834
| GYG1 | R228Q | Polyglucosan body myopathy type 2, Glycogen storage disease XV | Likely benign (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148744285
- GRCh38:
- Chr3:149026498
| GYG1 | R292T | Polyglucosan body myopathy type 2, Glycogen storage disease XV | Uncertain significance (Jul 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148712036
- GRCh38:
- Chr3:148994249
| GYG1 | A39T | Polyglucosan body myopathy type 2, Glycogen storage disease XV | Uncertain significance (Oct 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148714559-148714560
- GRCh38:
- Chr3:148996772-148996773
| GYG1 | E118fs | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Pathogenic (Aug 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148712003
- GRCh38:
- Chr3:148994216
| GYG1 | Q28* | Polyglucosan body myopathy type 2, Glycogen storage disease XV | Pathogenic (Oct 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148744563
- GRCh38:
- Chr3:149026776
| GYG1 | A282V, P209S, A299V | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Uncertain significance (Apr 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148744230
- GRCh38:
- Chr3:149026443
| GYG1 | | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Likely benign (Sep 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148741899
- GRCh38:
- Chr3:149024112
| GYG1 | T223I | Polyglucosan body myopathy type 2, Glycogen storage disease XV | Uncertain significance (Mar 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148714206
- GRCh38:
- Chr3:148996419
| GYG1 | | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Likely benign (Aug 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148744600-148744608
- GRCh38:
- Chr3:149026813-149026821
| GYG1 | | Polyglucosan body myopathy type 2, Glycogen storage disease XV | Uncertain significance (Oct 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148744568
- GRCh38:
- Chr3:149026781
| GYG1 | S284P, S301P | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Uncertain significance (Jul 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148744253-148744254
- GRCh38:
- Chr3:149026466-149026467
| GYG1 | Y282fs | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Pathogenic (Aug 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148727110
- GRCh38:
- Chr3:149009323
| GYG1 | T177A | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Uncertain significance (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148744638
- GRCh38:
- Chr3:149026851
| GYG1 | D234N, R324Q, R307Q | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Uncertain significance (May 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148742051
- GRCh38:
- Chr3:149024264
| GYG1 | V274I | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Uncertain significance (Dec 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148714105
- GRCh38:
- Chr3:148996318
| GYG1 | V54F | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Uncertain significance (Mar 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148742041
- GRCh38:
- Chr3:149024254
| GYG1 | | Polyglucosan body myopathy type 2, Glycogen storage disease XV | Likely benign (Sep 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148744528
- GRCh38:
- Chr3:149026741
| GYG1 | | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Likely benign (Jun 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148712033
- GRCh38:
- Chr3:148994246
| GYG1 | L38F | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Uncertain significance (Dec 25, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148741983
- GRCh38:
- Chr3:149024196
| GYG1 | N251I | Polyglucosan body myopathy type 2, Glycogen storage disease XV | Uncertain significance (Jul 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148711931
- GRCh38:
- Chr3:148994144
| GYG1 | Q4* | Polyglucosan body myopathy type 2, Glycogen storage disease XV | Pathogenic (Oct 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148714652
- GRCh38:
- Chr3:148996865
| GYG1 | Q148K | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Uncertain significance (Jun 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148741829
- GRCh38:
- Chr3:149024042
| GYG1 | | Polyglucosan body myopathy type 2, Glycogen storage disease XV | Likely benign (Mar 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148709432
- GRCh38:
- Chr3:148991645
| GYG1 | T2R | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Uncertain significance (Mar 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148712067
- GRCh38:
- Chr3:148994280
| GYG1 | | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Uncertain significance (Dec 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148742068
- GRCh38:
- Chr3:149024281
| GYG1 | | Polyglucosan body myopathy type 2, Glycogen storage disease XV | Likely benign (Mar 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148714218
- GRCh38:
- Chr3:148996431
| GYG1 | | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Likely benign (Jul 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148727188
- GRCh38:
- Chr3:149009401
| GYG1 | V203M | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Uncertain significance (Mar 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148727180
- GRCh38:
- Chr3:149009393
| GYG1 | A200V | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Uncertain significance (Jun 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148712083
- GRCh38:
- Chr3:148994296
| GYG1 | | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Likely benign (Dec 8, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148741914
- GRCh38:
- Chr3:149024127
| GYG1 | T228fs | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Pathogenic (Jul 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148741846
- GRCh38:
- Chr3:149024059
| GYG1 | | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Likely benign (Sep 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148741830
- GRCh38:
- Chr3:149024043
| GYG1 | | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Likely benign (Sep 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148741877
- GRCh38:
- Chr3:149024090
| GYG1 | R216* | Glycogen storage disease XV, Polyglucosan body myopathy type 2, not provided
| Pathogenic (Oct 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:148741981
- GRCh38:
- Chr3:149024194
| GYG1 | W250C | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Uncertain significance (Jul 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148742019
- GRCh38:
- Chr3:149024232
| GYG1 | Q263P | Glycogen storage disease XV, Polyglucosan body myopathy type 2, not specified
| Uncertain significance (May 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:148727080
- GRCh38:
- Chr3:149009293
| GYG1 | | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Benign (Apr 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148727049
- GRCh38:
- Chr3:149009262
| GYG1 | | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Likely benign (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148712050
- GRCh38:
- Chr3:148994263
| GYG1 | | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Likely benign (Apr 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148711967
- GRCh38:
- Chr3:148994180
| GYG1 | A16T | not provided, Polyglucosan body myopathy type 2, Glycogen storage disease XV
| Likely benign (Oct 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:148714070
- GRCh38:
- Chr3:148996283
| GYG1 | | Polyglucosan body myopathy type 2, Glycogen storage disease XV | Likely benign (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148744305
- GRCh38:
- Chr3:149026518
| GYG1 | | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Likely benign (Dec 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148711981
- GRCh38:
- Chr3:148994194
| GYG1 | | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Likely benign (Aug 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148714239
- GRCh38:
- Chr3:148996452
| GYG1 | | Polyglucosan body myopathy type 2, Glycogen storage disease XV | Likely benign (Oct 29, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148714254
- GRCh38:
- Chr3:148996467
| GYG1 | | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Likely benign (Feb 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148714119
- GRCh38:
- Chr3:148996332
| GYG1 | | Polyglucosan body myopathy type 2, Glycogen storage disease XV | Likely benign (Oct 6, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148714194
- GRCh38:
- Chr3:148996407
| GYG1 | | Polyglucosan body myopathy type 2, Glycogen storage disease XV | Likely benign (Aug 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148714197
- GRCh38:
- Chr3:148996410
| GYG1 | | Polyglucosan body myopathy type 2, Glycogen storage disease XV | Likely benign (Oct 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148744226
- GRCh38:
- Chr3:149026439
| GYG1 | | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Benign (Aug 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148741824
- GRCh38:
- Chr3:149024037
| GYG1 | | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Likely benign (May 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148712076
- GRCh38:
- Chr3:148994289
| GYG1 | | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Likely benign (Apr 23, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148744222
- GRCh38:
- Chr3:149026435
| GYG1 | | Polyglucosan body myopathy type 2, Glycogen storage disease XV | Likely benign (Apr 19, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148744669
- GRCh38:
- Chr3:149026882
| GYG1 | E244A | Polyglucosan body myopathy type 2, Glycogen storage disease XV | Likely benign (Nov 19, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148744663
- GRCh38:
- Chr3:149026876
| GYG1 | I242T | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Likely benign (Oct 13, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148741894
- GRCh38:
- Chr3:149024107
| GYG1 | | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Likely benign (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148714510
- GRCh38:
- Chr3:148996723
| GYG1 | | Polyglucosan body myopathy type 2, Glycogen storage disease XV | Likely benign (Feb 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148744609
- GRCh38:
- Chr3:149026822
| GYG1 | R224H | Polyglucosan body myopathy type 2, Glycogen storage disease XV | Likely benign (Jun 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148744585
- GRCh38:
- Chr3:149026798
| GYG1 | G216E | Polyglucosan body myopathy type 2, Glycogen storage disease XV | Likely benign (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148711914
- GRCh38:
- Chr3:148994127
| GYG1 | | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Likely benign (Jul 4, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148744672
- GRCh38:
- Chr3:149026885
| GYG1 | Q245P | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Likely benign (Feb 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148714229
- GRCh38:
- Chr3:148996442
| GYG1 | Y95C | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Uncertain significance (Aug 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148714148
- GRCh38:
- Chr3:148996361
| GYG1 | D68G | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Uncertain significance (Nov 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148744676
- GRCh38:
- Chr3:149026889
| GYG1 | S320T, S337T | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Uncertain significance (Oct 4, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148714693
- GRCh38:
- Chr3:148996906
| GYG1 | | Polyglucosan body myopathy type 2, Glycogen storage disease XV | Likely pathogenic (Sep 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148741986
- GRCh38:
- Chr3:149024199
| GYG1 | I252T | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Uncertain significance (Oct 5, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148709429
- GRCh38:
- Chr3:148991642
| GYG1 | M1K | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Uncertain significance (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148712045
- GRCh38:
- Chr3:148994258
| GYG1 | Q42K | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Uncertain significance (Jan 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148741995
- GRCh38:
- Chr3:149024208
| GYG1 | T255I | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Uncertain significance (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148711957
- GRCh38:
- Chr3:148994170
| GYG1 | N12K | Glycogen storage disease XV, Polyglucosan body myopathy type 2 | Uncertain significance (Dec 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:148741878
- GRCh38:
- Chr3:149024091
| GYG1 | R216Q | Inborn genetic diseases, Glycogen storage disease XV, Polyglucosan body myopathy type 2
| Uncertain significance (Jul 13, 2022) | criteria provided, multiple submitters, no conflicts |